LongRiver Investments
Asia, Shanghai, China, Xuhui'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
LRI Jiangyuan Investment continues to focus on the medical and technology fields.
Investor Profile
LongRiver Investments has backed more than 11 startups, with 6 new investments in the last 12 months alone. The firm has led 4 rounds, about 36% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 3 rounds in the past year.
Stage Focus
- Series B (45%)
- Series A (27%)
- Seed (18%)
- Angel (9%)
Country Focus
- China (64%)
- United States (27%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Pharmaceutical
- Medical Device
- Robotics
- App Discovery
- Data Center
- Devops
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
